BGPT: Paper Review: Amyloid Fibril Formation by the Glaucoma-Associated Olfactomedin Domain of Myocilin

Explore by Goal

Quick Explanation Copied

Amyloid behavior of myocilin’s OLF (myoc-OLF)

Using E. coli–expressed MBP-fused myoc-OLF and protease-resistant, SEC-fractionated “void-volume” species, the paper reports amyloid hallmarks: ThT-positive signal, PK resistance/proteolytic fragments, EM fibril-like morphologies, and A11 recognition of protofibrillar oligomers.
They then show de novo fibrillization (WT myoc-OLF) under mild conditions (37°C rocking) with nucleation/extension behavior and variant-dependent kinetics (e.g., Y437H faster; SDS or H2O2 can accelerate).
Finally, they report evidence for amyloid-containing aggregates from full-length myocilin in mammalian cells (CHO), with ThT staining and a “boiled-gel” mobility assay used as a proxy for amyloid-like SDS resistance.

Long Explanation

Paper Review (Visual + Critical): Amyloid Fibril Formation by the Glaucoma-Associated Olfactomedin Domain of Myocilin

DOI: 10.1016/j.jmb.2011.12.016 • Received/accepted Dec 2011 • Journal of Molecular Biology

What the paper claims (strictly from the provided full text)

Core claim: The glaucoma-associated olfactomedin (OLF) domain of myocilin (myoc-OLF) can form amyloid fibrils in vitro, showing multiple amyloid-associated signatures, and similar amyloid-like aggregates are detected in mammalian cells expressing full-length myocilin variants.

Mechanistic proposal: Fibrillization is nucleation-dependent and can be accelerated by destabilizing conditions (e.g., SDS below CMC; H2O2), with seeding and self-templating behavior; variants like Y437H fibrillize more readily.

Domain mapping: The amyloidogenic propensity appears to involve multiple regions of the myoc-OLF construct, with a notable loss of void-volume ThT positivity when residues 228–244 are truncated by introducing a stop codon at Tyr235.

Figure-style visualization (from the paper’s Table 1)

ThT intensity at 485 nm after 95 h (or 24 h for the 1.5% H2O2 footnote “a” in Table 1) under destabilizing conditions.

Critical note on interpretation: Table 1 includes a footnote indicating one H2O2 reading is taken at 24 h (not 95 h), so direct comparisons across all bars should be treated cautiously.

Am I convinced the aggregates are “amyloid”? (Skeptical triangulation)

Multiple, non-identical assays converge

ThT tinctorial response is reported as selective for SEC void-volume species (and for de novo fibrillization outcomes), including disease-variant OLF fusions.
Protease challenge (PK) is reported to retain ThT-positive void-volume peaks after PK treatment and SEC, which the authors interpret as resistance typical of tightly packed cross-β amyloid regions.
EM morphology is reported for negatively stained void-volume and PK-treated samples, describing discs/toroids/curvilinear strings with fibril-like width.
A11 antibody recognition is used as evidence for prefibrillar/protofibrillar oligomers in the aggregates they isolate.

Counterpoints / uncertainty

ThT is not amyloid-specific. The paper uses it as a marker for mature fibrils, but thioflavin assays can respond to other ordered aggregates; the paper partly addresses this by using orthogonal assays (PK, EM, A11), yet no high-resolution fibril structure (e.g., atomic-level polymorph identification) is provided in the provided full text.
Pre-existing heterogeneity from E. coli purification. The void-volume species appears already present prior to lysis and “does not interconvert” with monomer during handling, implying a pre-existing misfolded/aggregate-prone population. This is consistent with amyloidogenic seeds, but it also complicates causal interpretation about what forms during the in vitro “assay” conditions.
Domain mapping is suggestive, not exhaustive. The fragment experiments indicate multiple amyloid-prone segments but do not unambiguously yield a single minimal “core” sequence; the paper explicitly states that multiple cryptic amyloidogenic stretches may exist and future work is needed.
Cell culture translation is partial. The CHO evidence includes intracellular ThT positivity and a boiled-gel mobility proxy, but the paper does not establish fibril polymorph identity in vivo or directly test whether extracellular/topical eye conditions reproduce the same amyloid behavior.

Study design map (in vitro → seeding → cells → domain localization)

A quick “evidence-flow” graph based strictly on the paper’s experimental sequence.

What would most strongly change my interpretation?

Fibril identity mismatch. If future work demonstrates that ThT+/PK-resistant/EM-like material from myoc-OLF does not share the structural cross-β architecture expected of amyloid polymorphs (i.e., the assay cocktail yields ordered non-amyloid aggregates), then “amyloid” classification would be weakened. The paper itself frames amyloid detection as non-definitive (“no definitive test”).
In vivo relevance could be limited by missing cofactors. If the ocular microenvironment (e.g., extracellular matrix cofactors and/or TM stress context) does not recapitulate OLF fibrillization kinetics or favors different aggregate states, then the translational path could stall. The paper motivates environmental acceleration (oxidative/mechanical stress; TM aging) but treats it as a hypothesis requiring further testing.
Pre-existing seeds from bacterial expression. If the E. coli–derived void-volume species primarily represents a purification artifact and is not representative of what occurs in physiological production, then conclusions about domain-intrinsic aggregation would need recalibration. The paper argues against handling-dependent interconversion and discusses solubility/ultracentrifugation steps, but the causal chain remains indirect.

Actionable next scientific steps (hypothesis-splitting)

H1: myoc-OLF fibrillization is intrinsic and sequence-localized

The fragment stop-codon at Tyr235 abolishes a ThT-positive void-volume species, while other internal fragments remain ThT-positive, implying multiple amyloidogenic regions.

H2: in cells, fibrils occur in OLF-containing region and match the in vitro amyloid-like aggregates

The paper’s cell evidence uses ThT staining and a boiled-gel mobility proxy, but does not demonstrate that intracellular aggregates have the same structure as the in vitro fibrils.

Author Review Links (BGPT)

Jump to tailored BGPT author reviews for the authors listed in the provided paper header.

Feedback:

Updated: April 13, 2026